Approval · Notice of Compliance 11150 · 2010
VIVOTIF: Notice of Compliance 11150
Issued March 16, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11150
- Date
- March 16, 2010
- Company
- Crucell Switzerland Ltd
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIVOTIF | 00885975 | Marketed |
Medicinal ingredients
- TYPHOID VACCINE LIVE ORAL ATTENUATED TY21A 10 B per CAP